NEWPORT BEACH, Calif., Feb. 23, 2021 /PRNewswire/ — No World Borders, Inc. announced that genetic test billing expert Michael F. Arrigo published findings regarding insurance utilization, medical coding, and medical billing of genetic tests. He also shares findings regarding fraud waste and abuse in genetic testing.
Michael Arrigo, healthcare data, regulatory and economics expert in medical coding and billing, HIPAA Privacy and Security, Electronic Health Records, health care intellectual property
INTRODUCTIONGenomic medicine is revolutionizing medicine and creating new opportunities for predictive diagnosis and precision medicine. As a result, laboratory tests are now the highest-volume medical intervention.1 Over 6.5 billion laboratory tests are performed annually in the U.S. Diagnostic testing may impact greater than sixty-five percent (65%) of clinical decisions.2 Yet, overall mean rates of case specific over-utilization were 20.6%, and case specific underutilization was 44.8%.3
CHALLENGESThere have been concerns regarding the cost of testing. Yet, the healthcare industry has not developed the tools to evaluate the medical necessity, efficacy, and reasonable costs fairly. Furthermore, there are ethical and privacy concerns regarding genetic testing…